Alset Inc. (NASDAQ:AEI – Get Free Report) saw a significant drop in short interest in the month of August. As of August 31st, there was short interest totalling 4,300 shares, a drop of 83.5% from the August 15th total of 26,000 shares. Based on an average daily trading volume, of 52,700 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.1% of the company’s stock are short sold.
Alset Price Performance
NASDAQ AEI traded up $0.01 on Thursday, hitting $0.93. The stock had a trading volume of 803 shares, compared to its average volume of 72,939. The business’s fifty day moving average price is $1.14 and its 200 day moving average price is $0.94. Alset has a 52-week low of $0.46 and a 52-week high of $2.05. The stock has a market cap of $8.59 million, a price-to-earnings ratio of -0.14 and a beta of 1.27.
Alset (NASDAQ:AEI – Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported ($0.13) earnings per share (EPS) for the quarter. Alset had a negative return on equity of 56.77% and a negative net margin of 620.33%. The firm had revenue of $1.13 million during the quarter.
Insider Activity at Alset
Hedge Funds Weigh In On Alset
An institutional investor recently bought a new position in Alset stock. StoneX Group Inc. acquired a new position in shares of Alset Inc. (NASDAQ:AEI – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 277,001 shares of the company’s stock, valued at approximately $193,000. StoneX Group Inc. owned 3.00% of Alset at the end of the most recent quarter. Institutional investors and hedge funds own 2.74% of the company’s stock.
Alset Company Profile
Alset Inc engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea. It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments.
Featured Articles
- Five stocks we like better than Alset
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Leveraged ETFs to Multiply Returns
- What is MarketRankā¢? How to Use it
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Alset Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alset and related companies with MarketBeat.com's FREE daily email newsletter.